Trial Profile
A randomized, double-blind, multicenter, multifactorial, placebo-controlled, parallel group study to evaluate the efficacy and safety of valsartan and amlodipine combined and alone in hypertensive patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Oct 2023
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 30 Dec 2006 New trial record.